Toward Better End-of-Life Care: Strategies to Reduce Hospital Utilization and Improve Quality in Metastatic Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the ...
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback